by Jordana Choucair | Dec 1, 2021 | Payers
A new poll from Willis Towers Watson shows that nearly 85 percent of employers plan to offer COVID-19 testing or test employees regularly as they return to the workplace, 80 percent of which say they’ll do so weekly. More than half (57 percent) of employers...
by Jordana Choucair | Nov 24, 2021 | Payers
The Institute for Medicaid Innovation released a survey showing that the majority of health plans that participated in Medicaid managed care offered plans that aimed to address health inequities over the past year. Ninety-five percent gave targeted services to...
by Jordana Choucair | Nov 24, 2021 | Payers
The Kaiser Family Foundation released two briefs summarizing key prescription drug provisions and general health policy provisions in the House-passed Build Back Better Act. The prescription drug provision brief discusses the expected effects on people, program...
by Jordana Choucair | Nov 23, 2021 | Payers
Humana announced it reached a value-based care agreement with Minnesota-based health system Allina Health for the insurer’s Medicare Advantage (MA) members. The multiyear agreement will include emphasizing reimbursement to physicians based on health outcomes of...
by Jordana Choucair | Nov 22, 2021 | Payers
A new analysis from the Better Medicare Alliance found that the number of Medicare Advantage (MA) plans offering recently expanded supplemental benefits increased by 43 percent from 2021 to the 2022. Overall, MA plans that offered at least one of the five expanded...
by Jordana Choucair | Nov 18, 2021 | Payers
The Biden administration released an interim final rule that will require health insurers and employers to report a plethora of drug data to the federal government. Insurers would need to disclose the 50 most expensive drugs they cover and the 25 drugs that yield the...
Recent Comments